Abstract

Introduction: Adipose derived stromal/stem cells (ASCs) hold potential as cell therapeutics for a wide range of disease states; however, many expansion protocols rely on the use of fetal bovine serum (FBS) as a cell culture nutrient supplement. The current study explores the substitution of lysates from expired human platelets (HPLs) as an FBS substitute. Methods: Expired human platelets from an authorized blood center were lysed by freeze/thawing and used to examine human ASCs with respect to proliferation using hematocytometer cell counts, colony forming unit-fibroblast (CFU-F) frequency, surface immunophenotype by flow cytometry, and tri-lineage (adipocyte, chondrocyte, osteoblast) differentiation potential by histochemical staining. Results: The proliferation assays demonstrated that HPLs supported ASC proliferation in a concentration dependent manner, reaching levels that exceeded that observed in the presence of 10% FBS. The concentration of 0.75% HPLs was equivalent to 10% FBS when utilized in cell culture media with respect to proliferation, immunophenotype, and CFU-F frequency. When added to osteogenic, adipogenic, and chondrogenic differentiation media, both supplements showed appropriate differentiation by staining. Conclusion: HPLs is an effective substitute for FBS in the culture, expansion and differentiation of human ASCs suitable for pre-clinical studies; however, additional assays and analyses will be necessary to validate HPLs for clinical applications and regulatory approval.

Highlights

  • Adipose derived stromal/stem cells (ASCs) hold potential as cell therapeutics for a wide range of disease states; many expansion protocols rely on the use of fetal bovine serum (FBS) as a cell culture nutrient supplement

  • Human adipose-derived stromal/stem cells (ASCs) are derived from culture expanded stromal vascular fraction (SVF) cells isolated by collagenase digestion from adipose tissue harvested by tumescent liposuction or abdominoplasty [1]

  • To extend this line of research, the current study evaluated a human platelet lysate-derived substitute for FBS based on human ASC proliferation, colony forming unit-fibroblast (CFU-F), and differentiation assays

Read more

Summary

Introduction

Adipose derived stromal/stem cells (ASCs) hold potential as cell therapeutics for a wide range of disease states; many expansion protocols rely on the use of fetal bovine serum (FBS) as a cell culture nutrient supplement. Methods: Expired human platelets from an authorized blood center were lysed by freeze/thawing and used to examine human ASCs with respect to proliferation using hematocytometer cell counts, colony forming unit-fibroblast (CFU-F) frequency, surface immunophenotype by flow cytometry, and tri-lineage (adipocyte, chondrocyte, osteoblast) differentiation potential by histochemical staining. Conclusion: HPLs is an effective substitute for FBS in the culture, expansion and differentiation of human ASCs suitable for pre-clinical studies; additional assays and analyses will be necessary to validate HPLs for clinical applications and regulatory approval. FBS products introduce considerable cost to the manufacturing process relative to human platelet lysate due in part to reduced proliferation rates and the need for extended culture expansion periods [14]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call